513 related articles for article (PubMed ID: 3016712)
1. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
2. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
[TBL] [Abstract][Full Text] [Related]
3. Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b.
Wong WW; Klickstein LB; Smith JA; Weis JH; Fearon DT
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7711-5. PubMed ID: 2933745
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.
Moore MD; Cooper NR; Tack BF; Nemerow GR
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9194-8. PubMed ID: 2827171
[TBL] [Abstract][Full Text] [Related]
5. Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family.
Aegerter-Shaw M; Cole JL; Klickstein LB; Wong WW; Fearon DT; Lalley PA; Weis JH
J Immunol; 1987 May; 138(10):3488-94. PubMed ID: 2952719
[TBL] [Abstract][Full Text] [Related]
6. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.
Kurtz CB; Paul MS; Aegerter M; Weis JJ; Weis JH
J Immunol; 1989 Sep; 143(6):2058-67. PubMed ID: 2528587
[TBL] [Abstract][Full Text] [Related]
7. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
[TBL] [Abstract][Full Text] [Related]
8. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
[TBL] [Abstract][Full Text] [Related]
10. Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.
Hillarp A; Dahlbäck B
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1183-7. PubMed ID: 2300577
[TBL] [Abstract][Full Text] [Related]
11. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
13. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
Ahearn JM; Fearon DT
Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
[No Abstract] [Full Text] [Related]
15. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
Arvieux J; Yssel H; Colomb MG
Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
[TBL] [Abstract][Full Text] [Related]
16. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
Nemerow GR; Mold C; Schwend VK; Tollefson V; Cooper NR
J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
Carel JC; Myones BL; Frazier B; Holers VM
J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
[TBL] [Abstract][Full Text] [Related]
18. Identification of murine complement receptor type 2.
Fingeroth JD; Benedict MA; Levy DN; Strominger JL
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):242-6. PubMed ID: 2783485
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
Molina H; Brenner C; Jacobi S; Gorka J; Carel JC; Kinoshita T; Holers VM
J Biol Chem; 1991 Jul; 266(19):12173-9. PubMed ID: 1712014
[TBL] [Abstract][Full Text] [Related]
20. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21).
Fingeroth JD
J Immunol; 1990 May; 144(9):3458-67. PubMed ID: 2139457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
